Hansen Xu

Hansen Xu, Ph.D., is an Investment Manager with Lilly Asia Ventures (LAV). Prior to joining LAV, Hansen was a Project Leader and a member of the healthcare practice at Boston Consulting Group (BCG) Shanghai office, helping MNC and local pharma/biotech clients on various projects such as long term strategy, portfolio strategy, product launch support, and organizational structure changes among others. Hansen holds a Ph.D. in biochemistry from Cornell University and a B.A. in Chemistry from Cornell University.